
Erik N.K. Cressman, M.D., Ph.D., F.S.I.R.
Department of Interventional Radiology, Division of Diagnostic Imaging
About Dr. Cressman
Dr. Erik Cressman is an Associate Professor of Interventional Radiology at UT MD Anderson Cancer Center. Dr. Cressman received his Ph.D. in Organic Chemistry from the University of Utah in 1989 and his Doctorate in Medicine from Indiana University School of Medicine in 1999. He completed his residency in diagnostic radiology as well and was the inaugural B. Leonard Holman Scholar. Dr. Cressman did his fellowship training in Interventional Radiology, also at Indiana University, after which he began his career at the University of Minnesota as an Assistant Professor in 2005 where he served as Fellowship Program Director. In 2013, he joined UTMD Anderson Cancer Center and currently serves as a Research Advisor for the UTMDACC GSBS Ph.D. Advisory Committee. He served two terms as Chair of the Society of Interventional Radiology Grants and Research Division, is a past President of the Society of Thermal Medicine, and was elected a Fellow of the Society of Interventional Radiology. Dr. Cressman also served as the scientific program chair for the 2015 Society of Thermal Medicine annual meeting, Director of the John S. Dunn Center for Radiologic Sciences at MD Anderson, the Chemical Imaging Research Core, and runs the Image Guided Chemistry Lab. He has received numerous honors and awards for his contributions, primarily in new applications of chemistry in medicine. More recently, he served as scientific vice-chair for the 2022 Society of Interventional Radiology meeting. He currently is the workshop chair for the 2023 Society of Interventional Radiology meeting, a section editor for the International Journal of Hyperthermia, and a charter member of the Image Guided Interventions and Surgery (IGIS) study section at the National Institutes of Health. His research interests are in Tumor Heterogeneity and Metabolism, Thermochemistry, Cell Stress, Cancer Immunology, Thermal Imaging, and Mass Spectrometry Imaging. His clinical interests are in Embolization and Ablation, focused on primary liver cancer and metastatic disease. His goal is to improve patient care and outcomes by developing new approaches to minimally invasive, image-guided oncologic interventions based on the basic science of cancer and cell stress.
Present Title & Affiliation
Primary Appointment
Associate Professor, Department of Interventional Radiology, Division of Diagnostic Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX
Dual/Joint/Adjunct Appointment
Associate Professor, Department of Interventional Radiology, The University of Texas MD Anderson Cancer Center, Houston, TX
Education & Training
Degree-Granting Education
1999 | Indiana University School of Medicine, Indianapolis, Indiana, US, MD |
1989 | University of Utah, Salt Lake City, Utah, US, Organic Chemistry, Ph.D |
1983 | Goshen College, Goshen, Indiana, US, Chemistry, BA |
Postgraduate Training
2004-2005 | Clinical Fellowship, Interventional Radiology, Indiana University School of Medicine, Indianapolis, Indiana |
2000-2004 | Clinical Residency, Radiology, Indiana University School of Medicine, Indianapolis, Indiana |
1999-2000 | Clinical Internship, Transitional, St. Vincent Hospital, Indianapolis, Indiana |
Board Certifications
2014 | American Board of Radiology, Interventional Radiology/Diagnostic Radiology |
Experience & Service
Academic Appointments
Assistant Professor, Department of Interventional Radiology, The University of Texas MD Anderson Cancer Center, Houston, TX, 2013 - 2019
Assistant Professor, Department of Radiology, University of Minnesota, Minneapolis, MN, 2005 - 2013
Administrative Appointments/Responsibilities
Administrative Director, Department of Interventional Radiology, Chemical Imaging Research Core, The University of Texas MD Anderson Cancer Center, Houston, TX, 2015 - 2020
Administrative Director, Department of Interventional Radiology, John S Dunn Center for Radiologic Sciences, The University of Texas MD Anderson Cancer Center, Houston, TX, 2014 - 2021
Program Director, Department of Radiology, University of Minnesota, Interventional Radiology Fellowship, Minneapolis, MN, 2011 - 2013
Other Appointments/Responsibilities
Co-Chair, GEST Scientific Research Committee, 2021 - Present
Panelist, Global Embolization Oncology Symposium Technologies, New York, NY, 2019 - Present
Co-Chair, Global Embolization Oncology Symposium Technologies, New York, NY, 2019 - Present
Founding Member, Imaging Mass Spectrometry Society, Unionville, PA, 2017 - Present
Executive Committee, Society of Thermal Medicine, Lawrence, KS, 2016 - 2019
President, Society of Thermal Medicine, Lawrence, KS, 2015 - 2016
Chair, Society of Interventional Radiology, 2014 - 2020
Workshop Coordinator, Society of Interventional Radiology, 2014 - Present
Elected Fellow, Society of Interventional Radiology, 2014 - Present
Chair, Society of Interventional Radiology: Grants and Research Division, Fairfax, VA, 2014 - 2020
President Elect/ Program Chair, Society of Thermal Medicine, Lawrence, KS, 2014 - 2014
Elected Fellow, Society of Interventional Radiology, Fairfax, VA, 2014 - Present
Member, University of Minnesota Department of Radiology Operations Committee, Minneapolis, MN, 2012 - 2013
Member, University of Minnesota Physicians Compliance and Risk Management Committee, Minneapolis, MN, 2012 - 2013
Member, University of Minnesota Department of Radiology Graduate Education Committee, Minneapolis, MN, 2011 - 2013
Member, Faculty Search Committee, College of Veterinary Medicine, University of Minnesota, Minneapolis, MN, 2011 - 2012
Member, University of Minnesota Hospital Sedation Committee, Minneapolis, MN, 2011 - 2013
Member, Society of Interventional Radiology: Interventional Oncology Service Line Committee, Fairfax, VA, 2011 - 2017
Member, Society of Interventional Radiology: Grant Review Committee, Fairfax, VA, 2006 - Present
Member, Biomedical Engineering Institute, University of Minnesota, Minneapolis, MN, 2006 - 2013
Member, Society of Interventional Radiology: Research Policy Committee, Fairfax, VA, 2006 - 2014
Member, Society of Interventional Radiology: Research Education Committee, Fairfax, VA, 2006 - 2014
Member, Masonic Cancer Center, University of Minnesota, Minneapolis, MN, 2005 - 2013
Institutional Committee Activities
Nominations Judge, Academic Review Committee: 2021 Trainee Research Day - Endowed Fellowship Awards, 2021 - 2021
Member, Scientific Review Committee # 2 (SRC 2), 2020 - 2023
Member, Data and Biospecimen Access Committee (DBAC), 2020 - 2023
Member, INHANCE P01 Advisory Committee, 2019 - Present
Reviewer, Faculty Academic Review Committee, 2019 - 2019
Member, Internal Advisory Committee P01 2019 Head and Neck Symptom Research Working Group, 2019 - 2019
Member, MDACC Image-Guided Cancer Therapy (IGCT) Research Program, 2019 - Present
Reviewer, UTMDACC CCSG Radiation Oncology and Cancer Imaging Program (ROCIP), 2018 - Present
Member, DI Clinical Research Committee, 2018 - Present
Member, Institutional Animal Care and Use Committee (AACUC), 2017 - Present
Member, DI Trainee Research Symposium Committee, 2017 - 2017
Member, CABI MR Operations Committee Meeting, 2017 - Present
Member, Faculty Academic Review Committee (FARC), 2016 - Present
Research Advisor, UTMDACC GSBS PhD Advisory Committee, 2014 - Present
Member, Research Functional Committee, 2014 - Present
Honors & Awards
2023 | Distinguished Investigator Award, Academy for Radiology & Biomedical Imaging Research |
2014 | Elected Fellow, Society of Interventional Radiology |
2013 | SIR Leadership Academy, Society of Interventional Radiology |
2011 | Innovations Award, University of Minnesota |
2010 | Gary Becker Young Investigator Award, Society of Interventional Radiology Foundation |
2008 | Emerging Physicians Leadership Program, University of Minnesota |
2007 | Ernest J. Ring Faculty Development Award, Society of Interventional Radiology Foundation |
2003 | Outstanding Research Presentation Award, Campbell-Klatte Award |
2003 | Roentgen Research Resident Award, Radiological Society of North America |
2002 | CIRREF Travel Award, Innovation and Research in Interventional Radiology |
1998 | Medical Student Achievement Award, Endocrine Society |
1995 | Discovery Recognition Award, XR-874, Dow Elanco |
1979 | Menno Simons Scholar |
Professional Memberships
Selected Publications
Peer-Reviewed Articles
- Smetanick, D, Stolley, D, Fuentes, DA, Fowlkes, NW, Shakoor, F, Stenkamp, MS, Hicks, SC, Parrish, S, Cressman, EN. Volumetric CT Assessment of In Situ Induced Hepatic Lesions in a Transgenic Swine Model. Life 14(11), 2024. e-Pub 2024. PMID: 39598194.
- Smetanick D, Stolley D, Fuentes D, Fowlkes NW, Shakoor F, Stenkamp MS, Hicks S, Cressman ENK. Volumetric CT Assessment of In Situ Induced Hepatic Lesions in a Transgenic Swine Model. Life, 2024.
- Thompson, EA, Jacobsen, MC, Fuentes, DA, Layman, RR, Cressman, EN. Quantitative dual-energy computed tomography with cesium as a novel contrast agent for localization of thermochemical ablation in phantoms and ex vivo models. Medical physics 50(12):7879-7890, 2023. e-Pub 2023. PMID: 37409792.
- Thompson EA, Jacobsen MC, Fuentes DT, Layman RR, Cressman ENK. Quantitative dual-energy computed tomography with cesium as a novel contrast agent for localization of thermochemical ablation in phantoms and ex vivo models. Med Phys 50(12):7879-7890, 2023. e-Pub 2023.
- Özkan A, Stolley DL, Cressman ENK, McMillin M, Yankeelov TE, Rylander MN. Vascularized Hepatocellular Carcinoma on a Chip to Control Chemoresistance through Cirrhosis, Inflammation and Metabolic Activity. Small Struct 4(9), 2023. e-Pub 2023. PMID: 38073766.
- Thompson EA, Fowlkes NW, Jacobsen MC, Layman RR, Cressman ENK. Quantitative dual-energy computed tomography image guidance for thermochemical ablation: in vivo results in the rabbit VX2 model. J Vasc Interv Radiol 34(5):782-789, 2023. e-Pub 2023. PMID: 36539151.
- Özkan A, Stolley DL, Cressman ENK, McMillin M, DeMorrow S, Yankeelov TE, Rylander MN. Tumor microenvironment alters chemoresistance of hepatocellular carcinoma through CYP3A4 metabolic activity. Front Oncol 11:662135, 2021. e-Pub 2021. PMID: 34262860.
- Zuniga K, Gadde M, Scheftel J, Senecal K, Cressman E, Van Dyke M, Rylander MN. Collagen/kerateine multi-protein hydrogels as a thermally stable extracellular matrix for 3D in vitro models. Int J Hyperthermia 38(1):830-845, 2021. e-Pub 2021. PMID: 34058945.
- Fuentes D, Thompson E, Jacobsen M, Crouch AC, Layman RR, Riviere B, Cressman E. Imaging-based characterization of convective tissue properties. Int J Hyperthermia 37(3):155-63, 2020. e-Pub 2020. PMID: 33426993.
- Bensussan AV, Lin J, Guo C, Katz R, Krishnamurthy S, Cressman E, Eberlin LS. Distinguishing non-small cell lung cancer subtypes in fine needle aspiration biopsies by desorption electrospray ionization mass spectrometry imaging. Clin Chem 66(11):1424-1433, 2020. e-Pub 2020. PMID: 33141910.
- Gammon ST, Engel BJ, Gores GJ, Cressman E, Piwnica-Worms D, Millward SW. Mistiming death: Modeling the time-domain variability of tumor apoptosis and implications for molecular imaging of cell death. Mol Imaging Biol 22(5):1310-1323, 2020. e-Pub 2020. PMID: 32519246.
- Guo C, Baluya DL, Thompson EA, Whitley EM, Cressman ENK. Correlation of molecular and morphologic effects of thermoembolization in a swine model using mass spectrometry imaging. J Mass Spectrom 55(4):e4477, 2020. e-Pub 2020. PMID: 31804009.
- Einstein SA, Thompson EA, Guo C, Whitley EM, Bankson JA, Cressman ENK. Application of trifluoroacetic acid as a theranostic agent for chemical ablation of solid tissue. J Vasc Interv Radiol 31(1):169-175, 2020. e-Pub 2020. PMID: 31537410.
- Fuentes D, Fahrenholtz SJ, Guo C, MacLellan CJ, Layman RR, Rivière B, Stafford RJ, Cressman E. Mathematical modeling of mass and energy transport for thermoembolization. Int J Hyperthermia 37(1):356-365, 2020. e-Pub 2020. PMID: 32308071.
- Kok HP, Cressman ENK, Ceelen W, Brace CL, Ivkov R, Grüll H, Ter Haar G, Wust P, Crezee J. Heating technology for malignant tumors: a review. Int J Hyperthermia 37(1):711-741, 2020. e-Pub 2020. PMID: 32579419.
- Jacobsen MC, Cressman ENK, Tamm EP, Baluya DL, Duan X, Cody DD, Schellingerhout D, Layman RR. Dual-energy CT: Lower limits of iodine detection and quantification. Radiology 292(2):414-419, 2019. e-Pub 2019. PMID: 31237496.
- Cressman ENK. On the need for a taxonomy for interventional radiology: Initiating dialogue for the future. AJR Am J Roentgenol 212(2):1-4, 2019. e-Pub 2019. PMID: 30512993.
- Fahrenholtz SJ, Guo C, MacLellan CJ, Yung JP, Hwang KP, Layman RR, Stafford RJ, Cressman E. Temperature mapping of exothermic in situ chemistry: imaging of thermoembolization via MR. Int J Hyperthermia 36(1):730-738, 2019. e-Pub 2019. PMID: 31362538.
- Cressman ENK, Guo C. First in vivo test of thermoembolization: Turning tissue against itself using transcatheter chemistry in a porcine model. Cardiovasc Intervent Radiol 41(10):1611-1617, 2018. e-Pub 2018. PMID: 29872896.
- Singal A, Mattison LM, Soule CL, Ballard JR, Rudie EN, Cressman E, Iaizzo PA. Assessment of ablative therapies in swine: Response of respiratory diaphragm to varying doses. Ann Biomed Eng 46(7):947-959, 2018. e-Pub 2018. PMID: 29594687.
- Elhelf IAS, Albahar H, Shah U, Oto A, Cressman E, Almekkawy M. High intensity focused ultrasound: The fundamentals, clinical applications and research trends. Diagn Interv Imaging 99(6):349-359, 2018. e-Pub 2018. PMID: 29778401.
- Cressman ENK, Newton I, Larson AC, Woodrum DA, Srimathveeravalli G, Borrelli MJ, Hunt S, Johnson T, Kim CY, White S, Pereira PL, Katsanos K, Gaba RC. State of the research enterprise in IR and recommendations for the future: Proceedings from the Society of Interventional Radiology Foundation Investigator Development Task Force. J Vasc Interv Radiol 29(6):751-757, 2018. e-Pub 2018. PMID: 29709441.
- Cressman ENK, Guo C. Feasibility study using tissue as reagent for cancer therapy: endovascular ablation via thermochemistry. Convergent Science Physical Oncology 4, 2018. e-Pub 2018.
- Fuentes D, Muñoz NM, Guo C, Polak U, Minhaj AA, Allen WJ, Gustin MC, Cressman ENK. A molecular dynamics approach towards evaluating osmotic and thermal stress in the extracellular environment. Int J Hyperthermia 35(1):1-9, 2018. e-Pub 2018. PMID: 30303437.
- Cressman ENK, Guo C, Karbasian N. Image-guided chemistry altering biology: An in vivo study of thermoembolization. PLoS One 13(7):e0200471, 2018. e-Pub 2018. PMID: 30011300.
- Mitchell J, Tinkey PT, Avritscher R, Van Pelt C, Eskandari G, Konnath George S, Xiao L, Cressman E, Morris JS, Rashid A, Kaseb AO, Amin HM, Uthamanthil R. Validation of a preclinical model of diethylnitrosamine-induced hepatic neoplasia in Yucatan miniature pigs. Oncology 91(2):90-100, 2016. e-Pub 2016. PMID: 27305144.
- Whiting N, Hu J, Shah JV, Cassidy MC, Cressman E, Zacharias Millward N, Menter DG, Marcus CM, Bhattacharya PK. Real-time MRI-guided catheter tracking using hyperpolarized silicon particles. Sci Rep 5:12842, 2015. e-Pub 2015. PMID: 26239953.
- Aravalli RN, Cressman EN. Relevance of rabbit VX2 tumor model for studies on human hepatocellular carcinoma: A microRNA-based study. J Clin Med 4(12):1989-1997, 2015. e-Pub 2015. PMID: 26690234.
- Rostambeigi N, Dekarske AS, Austin EE, Golzarian J, Cressman EN. Cost effectiveness of radioembolization compared with conventional transarterial chemoembolization for treatment of hepatocellular carcinoma. J Vasc Interv Radiol 25(7):1075-84, 2014. e-Pub 2014. PMID: 24861664.
- Singal A, Soule C, Ballard J, Cressman E, Iaizzo P. Physiological tissue response to various ablative modalities. J. Med. Devices 8(2), 2014. e-Pub 2014.
- Shehata IA, Ballard JR, Casper AJ, Hennings LJ, Cressman E, Ebbini ES. High-intensity focused ultrasound for potential treatment of polycystic ovary syndrome: Toward a noninvasive surgery. Fertil Steril 101(2):545-51, 2014. e-Pub 2014. PMID: 24290002.
- Cressman ENK, Zbacnik AP. Development of a simple miniature thermochemical ablation device suitable for tumor ablation research in rodent models. Journal of Medical Devices 8(1), 2013. e-Pub 2013.
- Cressman EN, Jahangir DA. A hydrophobic gel phantom for study of thermochemical ablation: Initial results using a weak acid and weak base. Int J Hyperthermia 29(1):71-8, 2013. e-Pub 2013. PMID: 23311380.
- Siebert DR, Misselt A, Hunter D, Cressman E. Two cases of femoral arterial access through a previously placed StarClose clip. J Vasc Interv Radiol 24(9):1414-6, 2013. e-Pub 2013. PMID: 23973030.
- Aravalli RN, Cressman EN, Steer CJ. Hepatic differentiation of porcine induced pluripotent stem cells in-vitro. Vet J 194(3):369-74, 2012. e-Pub 2012. PMID: 22749116.
- Aravalli RN, Choi J, Mori S, Mehra D, Dong J, Bischof JC, Cressman EN. Spectroscopic and calorimetric evaluation of chemically induced protein denaturation in HuH-7 liver cancer cells and impact on cell survival. Technol Cancer Res Treat 11(5):467-73, 2012. e-Pub 2012. PMID: 22775334.
- Gleeslin M, Cressman EN. Thermochemical ablation: A device for a novel interventional concept. Journal of Medical Devices 6:015001 1-5, 2012. e-Pub 2012.
- Cressman EN, Geeslin MG, Shenoi MM, Hennings LJ, Zhang Y, Iaizzo PA, Bischof JC. Concentration and volume effects in thermochemical ablation in vivo: Results in a porcine model. Int J Hyperthermia 28(2):113-21, 2012. e-Pub 2012. PMID: 22335225.
- Cressman EN, Shenoi MM, Edelman TL, Geeslin MG, Hennings LJ, Zhang Y, Iaizzo PA, Bischof JC. In vivo comparison of simultaneous versus sequential injection technique for thermochemical ablation in a porcine model. Int J Hyperthermia 28(2):105-12, 2012. e-Pub 2012. PMID: 22335224.
- Hu G, Cressman E, He B. Magnetoacoustic imaging of human liver tumor with magnetic induction. Appl Phys Lett 98(2):23703, 2011. e-Pub 2011. PMID: 21301635.
- Farnam JL, Smith BC, Johnson BR, Estrada R, Edelman TL, Farah R, Cressman EN. Thermochemical ablation in an ex-vivo porcine liver model using acetic acid and sodium hydroxide: Proof of concept. J Vasc Interv Radiol 21(10):1573-8, 2010. e-Pub 2010. PMID: 20801679.
- Freeman LA, Anwer B, Brady RP, Smith BC, Edelman TL, Misselt AJ, Cressman EN. In vitro thermal profile suitability assessment of acids and bases for thermochemical ablation: Underlying principles. J Vasc Interv Radiol 21(3):381-5, 2010. e-Pub 2010. PMID: 20097094.
- Aravalli RN, Behnan Sahin M, Cressman EN, Steer CJ. Establishment and characterization of a unique 1 microm diameter liver-derived progenitor cell line. Biochem Biophys Res Commun 391(1):56-62, 2010. e-Pub 2010. PMID: 19896459.
- Cressman EN, Tseng HJ, Talaie R, Henderson BM. A new heat source for thermochemical ablation based on redox chemistry: Initial studies using permanganate. Int J Hyperthermia 26(4):327-37, 2010. e-Pub 2010. PMID: 20345271.
- Misselt AJ, Edelman TL, Choi JH, Bischof JC, Cressman EN. A hydrophobic gel phantom for study of thermochemical ablation: Initial results using a weak acid and weak base. J Vasc Interv Radiol 20(10):1352-8, 2009. e-Pub 2009. PMID: 19699659.
- Shenoi M, Cressman ENK. Thermochemical ablation: A novel technique for solid tumor therapy. J Med Devices 3(2). e-Pub 2009.
- Wang Y, Hong J, Cressman ENK, Arriaga E. Direct sampling from human liver tissue cross-sections for electrophoretic analysis of doxorubicin. Anal Chem 81(9):3321-3328, 2009. e-Pub 2009. PMID: 19323500.
- Cressman ENK. Image-guided thermochemical ablation: Theoretical and practical considerations. Conf Proc IEEE Eng Med Biol Soc:4291-4294, 2009. e-Pub 2009. PMID: 19964105.
- Cressman ENK. The road less traveled: Combining an MD and PhD to establish a research program in biomedicine. Conf Proc IEEE Eng Med Biol Soc:153, 2009. e-Pub 2009. PMID: 19964468.
- Aravalli RN, Steer CJ, Cressman EN. Molecular mechanisms of hepatocellular carcinoma. Hepatology 48(6):2047-63, 2008. e-Pub 2008. PMID: 19003900.
- McLennan G, Cressman ENK, Xu Y, Zhang D, Jagtap M, Jayaram HN. The effect of benzamide riboside in the VX2 model of liver cancer in rabbits. J Vasc Intervent Radiol 16(11):1499-1504, 2005. e-Pub 2005. PMID: 16319157.
- Cressman ENK, Winer-Muram HT, Farber J. Traumatic intrapericardial ascending aortic rupture: CT appearance. J Thorac Imaging 19(1):45-47, 2004. e-Pub 2004. PMID: 14712132.
- Steinberg HO, Cressman ENK, Wu Y, Hook G, Cronin J, Johnson A, Baron AD. Insulin mediated nitric oxide production is impaired in insulin resistance. Diabetes 46:24A, 1997. e-Pub 1997.
- Keck GE, Savin KA, Cressman ENK, Weglarz MA. Synthetic studies on the rhizoxins. II. An Approach to the C10-C26 subunit using substrate directed allylstannane additions to aldehydes. Tetrahedron Lett 37(19):3291-3294, 1996. e-Pub 1996.
- Keck GE, Savin KA, Cressman ENK, Abbott DE. Effects of olefin geometry on the stereochemistry of Lewis-acid mediated additions of crotylstannanes to aldehydes. J Org Chem 59(25):7889-7896, 1994. e-Pub 1994.
- Cressman ENK. Synthesis of an indolizidinedione oxime inhibitor of acetyl-coenzyme a carboxylase (ACCase). Biorg & Med Chem Lett 4(16):1983-1984, 1994. e-Pub 1994.
- Keck GE, Cressman ENK, Enholm EJ. Intramolecular allylstannane cyclizations in alkaloid synthesis: Application to the synthesis of pyrrolizidine alkaloids. J Org Chem 54:4345-4349, 1989. e-Pub 1989.
Invited Articles
- Cressman ENK, Spraggins JM. Viewing the future of IR through molecular histology: An overview of imaging mass spectrometry. J Vasc Interv Radiol 29(11):1543-1546.e1, 2018. e-Pub 2018. PMID: 30274858.
- Cressman ENK. Animal models for hepatocellular carcinoma: Another step in the right direction. J Vasc Interv Radiol 23:395-396, 2012. e-Pub 2012. PMID: 22365297.
Other Articles
- Sharma A, Cressman E, Attaluri A, Kraitchman DL, Ivkov R Current challenges in image-guided magnetic hyperthermia therapy for liver cancer. Nanomaterials (Basel) 12(16), 2022. PMID: 36014633.
- Adnan A, Muñoz NM, Prakash P, Habibollahi P, Cressman ENK, Sheth RA Hyperthermia and Tumor Immunity. Cancers (Basel) 13(11), 2021. PMID: 34063752.
- Habibollahi P, Sheth RA, Cressman ENK Histological correlation for radiofrequency and microwave ablation in the local control of hepatocellular carcinoma (HCC) before liver transplantation: A comprehensive review. Cancers (Basel) 13(1):104, 2020. PMID: 33396289.
- Stolley DL, Crouch AC, Özkan A, Seeley EH, Whitley EM, Rylander MN, Cressman ENK Combining chemistry and engineering for hepatocellular carcinoma: Nano-scale and smaller therapies. Pharmaceutics 12(12):1243, 2020. PMID: 33419304.
- Jacobsen MC, Thrower SL, Ger RB, Leng S, Court LE, Brock KK, Tamm EP, Cressman ENK, Cody DD, Layman RR Multi-energy computed tomography and material quantification: Current barriers and opportunities for advancement. Med Phys 47(8):3752-3771, 2020. PMID: 32453879.
- Özkan A, Stolley D, Cressman ENK, McMillin M, DeMorrow S, Yankeelov TE, Rylander MN The influence of chronic liver diseases on hepatic vasculature: A liver-on-a-chip review. Micromachines (Basel) 11(5):487, 2020. PMID: 32397454.
- Thompson EA, Gann LB, Cressman ENK Learning to successfully search the scientific and medical literature. Cell Stress Chaperones 24(2):289-293, 2019. PMID: 30840226.
- Singal A, Ballard J, Rudie E, Cressman E, Iaizzo P A review of therapeutic ablation modalities: Review article. The American Society of Mechanical Engineers 10(4), 2016.
- Aravalli RN, Cressman EN, Steer CJ Cellular and molecular mechanisms of hepatocellular carcinoma: An update. Arch Toxicol 87(2):227-47, 2013. PMID: 23007558.
- Aravalli RN, Steer CJ, Sahin MB, Cressman EN Stem cell origins and animal models of hepatocellular carcinoma. Dig Dis Sci 55(5):1241-50, 2010. PMID: 19513833.
- Thoreson AA, Harris TS, Cressman EN Refractory bleeding in a TIPS patient due to an aberrant left gastric vein. J Vasc Interv Radiol 20(7):988-90, 2009. PMID: 19555893.
- Aravalli RN, Golzarian J, Cressman EN Animal models of cancer in interventional radiology. Eur Radiol 19(5):1049-53, 2009. PMID: 19137307.
Abstracts
- Sharma A, Cressman ENK, Attaluri A, Kraitchman DL, Ivkov R. Current Challenges in Image-Guided Magnetic Hyperthermia Therapy for Liver Cancer. Nanomaterials 12:2768, 2022. e-Pub 2022.
- Stolley DL, Warar S, Thompson EA, Pogostin B, Yu M, McHugh K, Seeley EH, Crouch AC, Cressman ENK. Matrix-assisted laser desorption ionization mass spectrometry imaging characterization of an alkaline embolization solution for transarterial cancer therapy. 69th ASMS Conference on Mass Spectrometry and Allied Topics, 2021. e-Pub 2021.
- Warar S, Stolley D, Yu M, Thompson EA, Pogostin B, McHugh K, Crouch AC, Cressman ENK. Initial MALDI imaging characterization of ethiodized oil, a radiopaque hydrophobic multipurpose liquid used in cancer therapy. 69th ASMS Conference on Mass Spectrometry and Allied Topics, 2021. e-Pub 2021.
- Thompson EA, Stolley D, Jacobsen M, Yu M, Pogostin B, Seeley E, Crouch AC, Warar S, McHugh K, Layman R, Cressman ENK. Alkaline embolization in vivo: multi-modal feasibility study using computed tomography, fluoroscopy, and mass spectrometry imaging. 69th ASMS Conference on Mass Spectrometry and Allied Topics, 2021. e-Pub 2021.
- Thompson E, Einstein S, Bankson J, Cressman E. Chemoablation agent imaging with background-free 19F-MRI. AAPM Annual Meeting 2018, 2018. e-Pub 2018.
- Elhelf IAS, Albahar H, Shah U, Oto A, Cressman E, Almekkawy M. High intensity focused ultrasound: The fundamentals, clinical applications and research trends. Diagnostic and Interventional Imaging, 2018. e-Pub 2018. PMID: 29778401.
- Guo C, Muñoz N, Polak U, Gustin M, Karbasian N, Cressman E. Investigating the role of HSF1 in ablation: Combined stresses block protective responses in multiple human HCC cell lines. Society of Interventional Radiology 2018, 2018. e-Pub 2018.
- Guo C, McWatters A, Dixon K, Cressman E. Thermoembolization a fundamentally new and powerful direction in locoregional oncologic therapy. First results from an in vivo swine model. Journal of Vascular and Interventional Radiology, 2018. e-Pub 2018.
- Sheth RA, Cortes A, Muñoz N, Avritscher R, Cressman E, Gupta S. Molecularly targeted photothermal ablation for precision tumor therapy: initial preclinical results. Society of Interventional Radiology 2018, 2018. e-Pub 2018.
- Muñoz N, Polak U, Guo C, Gustin M, Minhaj A, Cressman E. Sublethal concurrent osmotic and thermal stresses readily overwhelm cytoprotective responses across multiple human HCC cell lines. Society of Interventional Radiology 2018, 2018. e-Pub 2018.
- Cressman E. What's new in chemical ablation. Radiological Society of North America 2017, 2017. e-Pub 2017.
- Baluya D, Guo C, Cressman E. Correlative studies using mass spectrometry imaging in interventional radiology. Imaging Mass Spectrometry Society, 2017. e-Pub 2017.
- Fahrenholtz SJ, Guo C, MacLellan CJ, Yung J, Hwang K, Stafford RJ, Cressman E. Tracking thermoembolization via multiparametric MRI. AAPM Meeting 2017, 2017. e-Pub 2017.
- Cressman E. Distinguishing non‐small cell lung cancer subtypes by desorption electrospray ionization mass spectrometry. American Society for Mass Spectrometry 2017, 2017. e-Pub 2017.
- Cressman E. Imaging mass spectrometry of image‐guided drug delivery (IGDD) in thermochemical ablation. American Society for Mass Spectrometry 2017, 2017. e-Pub 2017.
- Cressman E. Feasibility studies in imaging mass spectrometry for evaluating thermoembolization, a new interventional oncologic technique. American Society for Mass Spectrometry 2017, 2017. e-Pub 2017.
- Cressman E. Technical challenges of mass spectrometry imaging of doxorubicin localization in rat liver treated with drug‐eluting beads. American Society for Mass Spectrometry 2017, 2017. e-Pub 2017.
- Layman R, Guo C, Fahrenholtz S, Baluya D, Cressman E. Multi-energy computed tomography (MECT) imaging of endovascular ablation: Thermoembolization in an ex-vivo porcine kidney model. Society for Thermal Medicine Meeting 2017, 2017. e-Pub 2017.
- Layman R, Guo C, Fahrenholtz S, Baluya D, Cressman E. Theranostic multiplexed thermochemical ablation (MTCA): Tracking dichloroacetate using multi-energy computed tomography. Society for Thermal Medicine Meeting 2017, 2017. e-Pub 2017.
- Fahrenholtz S, Guo C, Yung J, Hwang K, Stafford RJ, Cressman E. MRI-based real-time characterization of thermoembolization. Society of Thermal Medicine Meeting 2017, 2017. e-Pub 2017.
- Elhelf I, Cressman E. High intensity focused ultrasound (HIFU): What junior radiologists need to know!. Society of Interventional Radiology 2017, 2017. e-Pub 2017.
- Benvenuto N, Cressman E. Real‐time monitoring of tumor‐specific indocyanine green hepatic photothermal ablation using photoacoustic imaging. Society of Interventional Radiology 2017, 2017. e-Pub 2017.
- Behl N, Nagel A, Cressman E, Umathum R, Fuentes D, Stafford RJ, Bachert P, Ladd M, Maier F. Time-resolved 23Na imaging for monitoring of thermochemical ablation injections. ISMRM meeting 2016, 2016. e-Pub 2016.
- Parikh R, Cressman E. Extreme exotherms using polyprotic acids with polyamines for thermochemical ablation. STM/ICHO Meeting 2016, 2016. e-Pub 2016.
- Partridge J, Cressman E. Complete neutralization of available nitrogen atoms in polyamines using dichloroacetic acid improves mass efficiency in thermochemical ablation. STM/ICHO Meeting 2016, 2016. e-Pub 2016.
- Muñoz N, Minhaj A, Guo C, Gustin M, Cressman E. Metabolic modulation with dichloroacetate sensitizes cells to hyperthermia in human hepatocellular carcinoma cell lines. Society of Interventional Radiology Meeting 2016, 2016. e-Pub 2016.
- Muñoz N, Minhaj A, Guo C, Gustin M, Cressman E. Dose escalation and mechanistic studies in combined thermal and osmotic stress in hepatocellular carcinoma cell lines. Society of Interventional Radiology 2016, 2016. e-Pub 2016.
- Parikh R, Cressman E. Using a drug as a reactant in multiplexed thermochemical ablation: Thermal profile of valproic acid, a histone deacetylase inhibitor, in reactions with polyamine. STM/ICHO Meeting 2016, 2016. e-Pub 2016.
- Partridge J, Cressman E. Hyperchemical ablation: Exothermic neutralization of organic amines with dichloroacetic acid. STM/ICHO Meeting 2016, 2016. e-Pub 2016.
- Guo C, Maclellan C, Jacobsen M, Stafford J, Cressman E. Transarterial delivery of a dichloroacetyl chloride/lipiodol mixture in porcine kidney: a proof of concept study for thermochemical embolization. STM/ICHO Meeting 2016, 2016. e-Pub 2016.
- Parikh R, Mitcham T, Bouchard R, Cressman E. Photoacoustic imaging for spectral characterization and thermography of ex vivo thermochemical ablation. STM/ICHO Meeting 2016, 2016. e-Pub 2016.
- Cressman ENK. Grants and education update: Proposal for a new direction. Society of Interventional Radiology Foundation Board Meeting 2015, 2015. e-Pub 2015.
- Shea L, Cressman E. Increasing energy density with polyprotic acids and polyamines for use in thermochemical ablation. Society for Thermal Medicine 32nd Annual Meeting, 2015. e-Pub 2015.
- Cressman E, Muñoz N. Synergistic cytotoxic effects of combined thermal and osmotic stress are consistent across multiple cell lines. Society for Thermal Medicine 32nd Annual Meeting, 2015. e-Pub 2015.
- Miles T, Cressman E. Evaluation of exotherms of the polyamine analog, diethylenetriamine, with partial to complete neutralization by acetic acid. Society for Thermal Medicine 32nd Annual Meeting, 2015. e-Pub 2015.
- Shea L, Dextraze K, Mitcham T, Gray J, Bouchard R, Cressman E. Photoacoustic ultrasound-guided real-time imaging of thermochemical ablation in ex vivo porcine liver. 2015 Society for Thermal Medicine 32nd Annual Meeting, 2015. e-Pub 2015.
- Miles T, Cressman E. Thermal profile of acetic acid analogues for potential use in thermochemical ablation. 2015 Society for Thermal Medicine 32nd Annual Meeting, 2015. e-Pub 2015.
- Miles T, Cressman E. Analysis of exotherms of ethanolamine derivatives in reactions with acetic acid. 2015 Society for Thermal Medicine 32nd Annual Meeting, 2015. e-Pub 2015.
- Maier F, MacLellan CJ, Fuentes D, Cressman E, K-P H, Yung JP, Hazle JD, Stafford RJ MR. Monitoring of thermochemical ablation injections. Interventional MRI Symposium, 2014. e-Pub 2014.
- Cressman, ENK. Hyperpolarized 29Si magnetic resonance - towards applications in MR guided catheter tracking and targeted imaging of cancer. ICMRBS XXVI Meeting 2014, 2014. e-Pub 2014.
- MacLellan CJ, Maier F, Cressman E. Monitoring thermochemical ablation using fast chemical shift magnetic resonance imaging. AAPM Annual Meeting, 2014. e-Pub 2014.
- Jones MA, Maier F, Stafford RJ, Cressman E. Modeling and validation of thermochemical ablation (TCA) in ex-vivo bovine liver. Society of Thermal Medicine Annual Meeting, 2014. e-Pub 2014.
- Cressman EN. Master's speak: Early disease, good performance status and focal lesion- Ablation and TACE. Global Embolization Symposium and Technologies, 2014. e-Pub 2014.
- Maier F, MacLellan CJ, Fuentes DAT, Stafford RJ, Hazle JD, Cressman E. Magnetic resonance guided thermo chemical ablation. Society of Thermal Medicine Annual Meeting, 2014. e-Pub 2014.
- MacLellan CJ, Maier F, Stafford RJ, Cressman E. Multi-parametric magnetic resonance imaging of thermochemical ablation. Translational Science Meeting, 2014. e-Pub 2014.
- Carroll P, Cressman ENK, Ebbini ES, Ballard J, Shehata IA, Haritonova. A Dual mode ultrasound array imaging interpretation for high intensity focused ultrasound therapy in ex vivo models. Society of Interventional Radiology Annual Meeting, 2014. e-Pub 2014.
- Gursahaney D S, Cressman ENK. Exothermic neutralization of valproic acid: combination thermochemical ablation with drug therapy. Society of Interventional Radiology Annual MeetinG, 2014. e-Pub 2014.
- Rostambeigi N, Dekarske A, Austin E, Golzarian J, Cressman ENK. Simulations study on cost-effectiveness of radioembolization compared with trans-arterial chemoembolization for hepatocellular carcinoma. Society of Interventional Radiology Annual Meeting, 2014. e-Pub 2014.
- Whiting N, Hu J, Shaw J, Cassidy M, Cressman E, Marcus C, Bhattacharya P. Real-time MRI-guided catheter tracking using hyperpolarized silicon nanoparticles. Experimental Nuclear Magnetic Resonance Conference, 2014. e-Pub 2014.
- Valesano J, Cressman E. Valporic acid as imageable, multifunctional chemoablative agent. Radiological Society of North America 99th Scientific Assembly and Annual Meeting, 2013. e-Pub 2013.
- Mortazavi S, Taylor AJ, Golzarian J, Kowalik KJ, Cressman ENK. Transarterial Lipiodiol–Ethanol Ablation of the Hepatocellular Carcinoma; a single center initial U.S. experience. Society of Interventional Radiology 2013 Annual Meeting, 2013. e-Pub 2013.
- Shehata IA, Ballard JR, Casper AJ, Cressman ENK. Feasibility of using high intensity focused ultrasound for treatment of polycystic ovarian syndrome: Potential for non-invasive surgical approach. Society of Interventional Radiology 2013 Annual Meeting, 2013. e-Pub 2013.
- Shehata I, Ballard J, Casper A, Cressman ENK. Ebbini E Feasibility of high intensity focused ultrasound (HIFU) for treatment of polycystic ovarian syndrome: Potential for non-invasive treatment. Society of Interventional Radiology 2013 Annual Meeting, 2013. e-Pub 2013.
- Shehata IA, Ballard JR, Casper AJ, Cressman ENK. Multiple-Focus Strategy For Volume Ablation Using Dual Mode Ultrasound Array (DMUA) Systems: Uniform Tissue Ablation In A Fraction Of The Time 3rd International Symposium on Focused Ultrasound. 3rd International Symposium on Focused Ultrasound, 2012. e-Pub 2012.
- Kuehn-Hajder J, Emory T, Cressman ENK. PQI Ultrasound Lectures: Moodle Based online modules and conference-based lectures. Resident Research Symposium, 2012. e-Pub 2012.
- Shehata I, Ballard J, Casper A, Cressman ENK. Feasibility of targeting atheromatous plaques by High Intensity Focused Ultrasound using Dual-Mode transducers: An early experience. SIR 2012 Annual Meeting, 2012. e-Pub 2012.
- Wood M, Cressman ENK, Casper A, Ballard J, Liu D, Haritonova A, Ebbini E. Dynamic dual mode ultrasound arrays for high intensity focused ultrasound therapy in an ex vivo model. Society of Interventional Radiology 2012 Annual Meeting, 2012. e-Pub 2012.
- Shenoi M, Geeslin MG, Cressman ENK. Thermochemical Ablation In-Vivo: An Acute Dose Escalation Study. World Conference of Interventional Oncology, 2011. e-Pub 2011.
- Aravalli R, Choi J, Mori S, Mehra D, Dong J, Bischof JC, Cressman, ENK. Scanning fourier transform infra-red (FTIR) evaluation of the impact of protein denaturation on survival after thermochemical ablation of HUH-7 liver cancer. Society of Thermal Medicine Annual Meeting, 2011. e-Pub 2011.
- Shenoi M, Geeslin MG, Cressman ENK. Thermochemical ablation in vivo: comparison of two injection methods in a porcine model. Society of Thermal Medicine Annual Meeting, 2011. e-Pub 2011.
- Shenoi M, Geeslin MG, Cressman ENK. In vivo simultaneous versus sequential thermochemical ablation: imaging, histopathology, and physiologic responses. World Conference of Interventional Oncology, 2011. e-Pub 2011.
- Shenoi M, Geeslin MG, Cressman ENK. In vivo thermochemical ablation using sodium hydroxide and acetic acid in a porcine model: temperature, coagulation volume, and sphericity analyses. Society of Thermal Medicine Annual Meeting, 2011. e-Pub 2011.
- Kowalik KJ, Cressman ENK. Transarterial chemoembolization in patients with elevated serum bilirubin. European Congress of Radiology, 2011. e-Pub 2011.
- Casper A, Ballard J, Liu D, Cressman ENK. Dual mode ultrasound array (DMUA) systems for image-guided surgery. World Conference of Interventional Oncology, 2010. e-Pub 2010.
- Verdoorn J, Farah R, Cressman ENK. Malonyl chloride as a powerful thermochemical ablation agent: Ex vivo volume studies and histological analysis. World Conference of Interventional Oncology, 2010. e-Pub 2010.
- Cressman ENK, H-J T, Talaie R, Henderson B. Redox chemistry: a powerful energy source for thermochemical ablation. Society of Thermal Medicine Annual Meeting, 2010. e-Pub 2010.
- Farnam J, Anwer U, Cressman ENK. Trifluoroacetic acid: a thermochemical ablation agent with 19F MRI potential. Society of Thermal Medicine Annual Meeting, 2010. e-Pub 2010.
- Ryan Roberts R, Andrew Thoreson A, Cressman ENK. Polyprotic mineral acids as powerful reagents in thermochemical ablation. Society of Thermal Medicine Annual Meeting, 2010. e-Pub 2010.
- Jahangir D, Turner K, Pfeifer K, Cressman ENK. Assessment of acetyl chloride and acetic anhydride as exothermic electrophiles for thermochemical ablation. Society of Thermal Medicine Annual Meeting, 2009. e-Pub 2009.
- Johnson JB, Edelman TL, Cressman ENK. Controlling power input in thermochemical ablation: Injection volume as a variable. Society of Thermal Medicine Annual Meeting, 2009. e-Pub 2009.
- Shenoi M, Cressman ENK. Thermochemical ablation A novel technique for solid tumor therapy. 6th Annual Design of Medical Devices Conference, University of Minnesota, 2009. e-Pub 2009.
- Abdihalim M, Edelman TL, Cressman ENK. Hyperthermic ethanol generated in situ: Initial assessment of the electrophile ethyl chloroformate for thermochemical ablation. 6th Annual Design of Medical Devices Conference, 2009. e-Pub 2009.
- Farnam J, Farah R, Cressman ENK. Thermochemical ablation using an acetic acid and sodium hydroxide neutralization. Al Michael Student Research Colloquium University of Minnesota, 2009. e-Pub 2009.
- Hackett PB, Urness M, Bell JB, Olson ER, Aronovich EL, Cressman ENK, Castaneda-Zuniga WR, Hunter DW, McIvor RS. Use of non-invasive balloon catheters placed under fluoroscopic guidance for delivery of the sleeping beauty transposon system under pressure to the liver of dogs. 11th Annual Meeting of the American Society of Gene Therapy, 2008. e-Pub 2008.
- Brix TL, Dye DF, Zaleski JM, Kren BT, Cressman ENK. Cytotoxicity of heterocyclic enediynes in HuH7 and HeLa cells. University of Minnesota, 2007. e-Pub 2007.
- Cressman ENK, Mclennan G, Jayaram HN, Hutchins GD. Preliminary results of in vivo effects of benzamide riboside on rabbit VX2 liver tumors. Innovation and Research in Interventional Radiology: Interventional Oncology from Benchtop to Bedside, 2002. e-Pub 2002.
- Keck GE, Savin KA, Cressman ENK. Studies directed toward the synthesis of the rhizoxins. 205th National ACS Meeting, 1993. e-Pub 1993.
- Keck GE, Cressman ENK. Studies in pyrrolizidine alkaloid synthesis. 193rd ACS National Meeting, 1987. e-Pub 1987.
- Munoz-Gonzalez N, Tam A, Avritscher R, Cressman ENK, Sheth R. Intratumoral delivery of immunotherapeutics: Optimizing drug delivery for improved treatment efficacy.
- Spors M, Karbasian N, Thompson E, Jacobsen M, Cressman E. An examination of the novel use of cesium hydroxide as a contrast agent in thermochemcical ablation.
Book Chapters
- Cressman ENK. Image-guided cancer therapies. In: Image-Guided Cancer Therapies: A Multipledisciplinary Approach. Springer, 2013.
- Cressman ENK. Thermochemical ablation. In: Physics of Thermay Therapy: Fundamentals and Clinical Applications. Taylor 7 Francis/CRC Press, 2012.
- Cressman ENK. The biological effects of embolization. In: Transcatheter Embolization and Therapy. Springer, 2010.
- Cressman ENK. Interventional therapies. In: Living Donor Organ Transplantation. McGraw Hill, 2008.
Selected Presentations & Talks
Regional Presentations
- 2019. Ablation or resection: When and why?. Conference. Ablation or resection: When and why?. New York, NY, US.
- 2019. Exploring the abscopal effect: Potential synergy combining liver directed therapy with immunotherapeutics. Conference. Exploring the abscopal effect: Potential synergy combining liver directed therapy with immunotherapeutics. New York, NY, US.
- 2018. Research funding opportunities for residents and medical students. Conference. Research funding opportunities for residents and medical students, US.
- 2018. Getting started in research in IR. Conference. Getting started in research in IR, US.
National Presentations
- 2024. OBX-115, an interleukin 2 (IL2)-sparing engineered tumor-infiltrating lymphocyte (TIL) cell therapy, in patients (pts) with immune checkpoint inhibitor (ICI)-resistant unresectable or metastatic melanoma. Conference. OBX-115, an interleukin 2 (IL2)-sparing engineered tumor-infiltrating lymphocyte (TIL) cell therapy, in patients (pts) with immune checkpoint inhibitor (ICI)-resistant unresectable or metastatic melanoma. Chicago, IL, US.
- 2024. Turning cold to hot: Tumor microenvironments what an IR should know. Conference. New York, New york, US.
- 2024. Heat, cold, electricity, and chemicals - Choosing a modality to ablate HCC. Conference. Global Embolization Oncology Symposium Technologies (GEST) 2024. New York, New York, US.
- 2024. Trace Levels of Valproate Detected In Plasma Following Reactive Embolization In Vivo In A Pig Model. Conference. New York, New York, US.
- 2024. Volumetric CT Assessment of In Situ Induced Hepatic Lesions of An Oncopig Model. Conference. Volumetric CT Assessment of In Situ Induced Hepatic Lesions of An Oncopig Model. Salt Lake City, UT, US.
- 2023. Moderator: Best Scientific Abstracts & Awards. Conference. Moderator: Best Scientific Abstracts & Awards. New York, NY, US.
- 2023. Feasibility Study of Alkaline Solutions in Embolotherapy. Conference. Feasibility Study of Alkaline Solutions in Embolotherapy. New York City, NY, US.
- 2023. Initial experience with an inducible transgenic tumor model in swine. Conference. Initial experience with an inducible transgenic tumor model in swine. New York City, NY, US.
- 2023. Hot and Cold: Why do they keep talking about tumor temperature?. Conference. Hot and Cold: Why do they keep talking about tumor temperature?. New York City, NY, US.
- 2023. Liver tumor or liver tumor?. Conference. Liver tumor or liver tumor?. San Diego, CA, US.
- 2022. Moderator: How to think like your C-Suite: Plenary Session with Abstracts of the Year Recognition. Conference. Moderator: How to think like your C-Suite: Plenary Session with Abstracts of the Year Recognition. Boston, MA, US.
- 2022. Moderator: Scientific Poster Reception and Awards Recognition. Conference. Moderator: Scientific Poster Reception and Awards Recognition. Boston, MA, US.
- 2022. Interpreting localized features associated with ablated liver tissue after image-guided multiplexed endovascular therapies. Conference. Interpreting localized features associated with ablated liver tissue after image-guided multiplexed endovascular therapies. Minneapolis, MN, US.
- 2022. Mass spectrometry imaging for protein localization and characterization in thermoembolized hepatic porcine tissue. Conference. Mass spectrometry imaging for protein localization and characterization in thermoembolized hepatic porcine tissue. Minneapolis, MN, US.
- 2022. Mick Jagger was right, you can't always get what you want. Adventures in Thermochemistry. Conference. Mick Jagger was right, you can't always get what you want. Adventures in Thermochemistry, US.
- 2021. Basic & Translational Research in IR? How I Got Started. Conference. Basic & Translational Research in IR? How I Got Started. Chicago, IL, US.
- 2021. Alkaline embolization in vivo: Multi-modal feasibility study using computed tomography, fluoroscopy, and mass spectrometry imaging. Conference. Alkaline embolization in vivo: Multi-modal feasibility study using computed tomography, fluoroscopy, and mass spectrometry imaging. Philadelphia, PA, US.
- 2021. Initial MALDI imaging characterization of ethiodized oil, a radiopaque hydrophobic multipurpose liquid used in cancer therapy. Conference. Initial MALDI imaging characterization of ethiodized oil, a radiopaque hydrophobic multipurpose liquid used in cancer therapy. Philadelphia, PA, US.
- 2021. Matrix-assisted laser desorption ionization mass spectrometry imaging characterization of an alkaline embolization solution for transarterial cancer therapy. Conference. Matrix-assisted laser desorption ionization mass spectrometry imaging characterization of an alkaline embolization solution for transarterial cancer therapy. Philadelphia, PA, US.
- 2021. Clinical IMS. Conference. Clinical IMS. Colorado Springs, CO, US.
- 2021. Chemoembolization: The next frontier. Conference. Chemoembolization: The next frontier, US.
- 2021. Quantitative DECT for image-guided thermochemical ablation: An in vivo study. Conference. Quantitative DECT for image-guided thermochemical ablation: An in vivo study, US.
- 2021. Energy Based Devices or Ablation without Photons in 103 Seconds. Conference. Energy Based Devices or Ablation without Photons in 103 Seconds, US.
- 2020. Quantitative image-guided DECT interventions: A potential new theranostic for thermochemical ablation. Conference. Quantitative image-guided DECT interventions: A potential new theranostic for thermochemical ablation. Alexandria, VA, US.
- 2020. Comparison of IMAR and AiMAR techniques for metal artifact reduction in CT-guided microwave ablations. Conference. Comparison of IMAR and AiMAR techniques for metal artifact reduction in CT-guided microwave ablations. Alexandria, VA, US.
- 2019. Multimodal analysis through mass spectrometry imaging and multi-energy tomography using cesium as an integrative marker. Conference. Multimodal analysis through mass spectrometry imaging and multi-energy tomography using cesium as an integrative marker. Atlanta, GA, US.
- 2019. Mass spectrometry imaging of dichloroacetate for evaluating the effects of thermoembolization in-vivo with CT correlation. Conference. Mass spectrometry imaging of dichloroacetate for evaluating the effects of thermoembolization in-vivo with CT correlation. Atlanta, GA, US.
- 2019. Mathematical model developments for thermoembolization. Conference. Mathematical model developments for thermoembolization. St Pete Beach, FL, US.
- 2019. Tissue microarray analysis of morphology and mechanisms of tissue damage by thermal, chemical, and thermochemical modalities. Conference. Tissue microarray analysis of morphology and mechanisms of tissue damage by thermal, chemical, and thermochemical modalities. St Pete Beach, FL, US.
- 2019. First detailed pathology of hepatic thermoembolization in a swine model. Conference. First detailed pathology of hepatic thermoembolization in a swine model. St Pete Beach, FL, US.
- 2019. Transcriptome analysis indicates that combined thermal and osmotic stresses cause widespread compromise of cytoprotective responses in HepG2 cells. Conference. Transcriptome analysis indicates that combined thermal and osmotic stresses cause widespread compromise of cytoprotective responses in HepG2 cells. St Pete Beach, FL, US.
- 2019. MEK inhibition enhances sensitivity to thermal ablation by blunting HSF1 activation in HepG2 cells. Conference. MEK inhibition enhances sensitivity to thermal ablation by blunting HSF1 activation in HepG2 cells. St Pete Beach, FL, US.
- 2019. Applications of 19F magnetic resonance imaging in thermochemistry with pathologic correlation. Conference. Applications of 19F magnetic resonance imaging in thermochemistry with pathologic correlation. St Pete Beach, FL, US.
- 2019. Thermochemical ablation and the necessity of a multi-modal imaging approach. Conference. Thermochemical ablation and the necessity of a multi-modal imaging approach. St Pete Beach, FL, US.
- 2019. Feasibility of CT thermometry of laser ablations in ex-vivo porcine liver. Conference. Feasibility of CT thermometry of laser ablations in ex-vivo porcine liver. St Pete Beach, FL, US.
- 2019. A new, tunable, multimodal strategy for ablation: Exothermic reaction of thioglycolic acid for thermal denaturation whilst targeting disulfide bonds to alter protein structure. Conference. A new, tunable, multimodal strategy for ablation: Exothermic reaction of thioglycolic acid for thermal denaturation whilst targeting disulfide bonds to alter protein structure. St Pete Beach, FL, US.
- 2019. An examination of the novel use of cesium hydroxide as a contrast agent in thermochemical ablation or evaluating utility of cesium for real-time tracking and correlation studies in thermochemical ablation. Conference. An examination of the novel use of cesium hydroxide as a contrast agent in thermochemical ablation or evaluating utility of cesium for real-time tracking and correlation studies in thermochemical ablation. Austin, TX, US.
- 2019. Semi-quantitative mapping of oncological therapies with mass spectrometry imaging. Conference. Semi-quantitative mapping of oncological therapies with mass spectrometry imaging. Atlanta, GA, US.
- 2019. Intratumoral delivery of immunotherapeutics: Optimizing drug delivery for improved treatment efficacy. Conference. Intratumoral delivery of immunotherapeutics: Optimizing drug delivery for improved treatment efficacy. Austin, TX, US.
- 2019. Immunologic ramifications of tumor-specific hyperthermia in a preclinical model of hepatocellular carcinoma. Conference. Immunologic ramifications of tumor-specific hyperthermia in a preclinical model of hepatocellular carcinoma. Austin, TX, US.
- 2018. Limits for detecting low concentrations of iodine with dual-energy computed tomography. Conference. Limits for detecting low concentrations of iodine with dual-energy computed tomography. Chicago, IL, US.
- 2018. Mass profiling of a large animal tumor model: Lipid biomarkers of rabbit VX2. Conference. Mass profiling of a large animal tumor model: Lipid biomarkers of rabbit VX2. Charleston, SC, US.
- 2018. Thermochemical ablation. Conference. Thermochemical ablation. Chicago, IL, US.
- 2018. Chemoablation agent imaging with background-free 19F-MRI. Conference. Chemoablation agent imaging with background-free 19F-MRI. Nashville, TN, US.
- 2018. IR: Looking beyond photon attenuation and echogenicity. Conference. IR: Looking beyond photon attenuation and echogenicity. Philadelphia, PA, US.
- 2018. Valproic acid as a theranostic agent: Computed tomography and mass spectrometry imaging of an imageable ablation agent with anti-tumor properties. Conference. Valproic acid as a theranostic agent: Computed tomography and mass spectrometry imaging of an imageable ablation agent with anti-tumor properties. San Diego, CA, US.
- 2018. Mass spectrometry imaging in chemical ablation of tissues: Novel application of trifluoracetic acid for cancer therapy. Conference. Mass spectrometry imaging in chemical ablation of tissues: Novel application of trifluoracetic acid for cancer therapy. San Diego, CA, US.
- 2018. Carcinogenesis and immunology. Conference. Carcinogenesis and immunology. Miami, FL, US.
- 2018. In vivo hyperthermic electrophilic hydrolysis: Thermoembolization in swine liver. Conference. In vivo hyperthermic electrophilic hydrolysis: Thermoembolization in swine liver. Tucson, AZ, US.
- 2018. Combined mild hyperosmotic and hyperthermal stresses overcome the cell survival mechanisms of multiple human hepatocellular cancer cell lines. Conference. Combined mild hyperosmotic and hyperthermal stresses overcome the cell survival mechanisms of multiple human hepatocellular cancer cell lines. Tucson, AZ, US.
- 2018. Convergent toxicity of hyperthermic and osmotic stress sensitizes HCC cells by inhibition of HSF1. Conference. Convergent toxicity of hyperthermic and osmotic stress sensitizes HCC cells by inhibition of HSF1. Tucson, AZ, US.
- 2018. MRI thermal monitoring of thermoembolization. Conference. MRI thermal monitoring of thermoembolization. Tucson, AZ, US.
- 2018. A molecular dynamics approach for evaluating osmotic and thermal stress on extracellular proteins. Conference. A molecular dynamics approach for evaluating osmotic and thermal stress on extracellular proteins. Tucson, AZ, US.
- 2018. Session XI: Update on medical therapy for MCRC: Current guidelines. Conference. Session XI: Update on medical therapy for MCRC: Current guidelines. Miami, FL, US.
- 2018. Case-based discussion: Complex ablation. Conference. Case-based discussion: Complex ablation. Miami, FL, US.
- 2018. Session XI: Immunotherapy for MCRC: Emerging data. Conference. Session XI: Immunotherapy for MCRC: Emerging data. Miami, FL, US.
- 2018. Real time quantitative CT monitoring of thermochemistry by novel application of CsOH. Conference. Real time quantitative CT monitoring of thermochemistry by novel application of CsOH. Tucson, AZ, US.
- 2018. Investigating the role of HSF1 in ablation: Combined stresses block protective responses in multiple human HCC cell lines. Conference. Investigating the role of HSF1 in ablation: Combined stresses block protective responses in multiple human HCC cell lines. Los Angeles, CA, US.
- 2018. Molecularly targeted photothermal ablation for precision tumor therapy: initial preclinical results. Conference. Molecularly targeted photothermal ablation for precision tumor therapy: initial preclinical results. Los Angeles, CA, US.
- 2018. Thermoembolization, a fundamentally new and powerful direction in locoregional oncologic therapy. First results from an in vivo swine model. Conference. Thermoembolization, a fundamentally new and powerful direction in locoregional oncologic therapy. First results from an in vivo swine model. Los Angeles, CA, US.
- 2018. Sublethal concurrent osmotic and thermal stresses readily overwhelm cytoprotective responses across multiple human HCC cell lines. Conference. Sublethal concurrent osmotic and thermal stresses readily overwhelm cytoprotective responses across multiple human HCC cell lines. Los Angeles, CA, US.
- 2017. What's new in chemical ablation. Conference. What's new in chemical ablation. Chicago, IL, US.
- 2017. Correlative studies using mass spectrometry imaging in interventional radiology. Conference. Correlative studies using mass spectrometry imaging in interventional radiology. Waltham, MA, US.
- 2017. Tracking thermoembolization via multiparametric MRI. Conference. Tracking thermoembolization via multiparametric MRI. Denver, CO, US.
- 2017. Technical challenges of mass spectrometry imaging of doxorubicin localization in rat liver treated with drug‐eluting beads. Conference. Technical challenges of mass spectrometry imaging of doxorubicin localization in rat liver treated with drug‐eluting beads. Indianapolis, IN, US.
- 2017. Feasibility studies in imaging mass spectrometry for evaluating thermoembolization, a new interventional oncologic technique. Conference. Feasibility studies in imaging mass spectrometry for evaluating thermoembolization, a new interventional oncologic technique. Indianapolis, IN, US.
- 2017. Imaging mass spectrometry of image‐guided drug delivery (IGDD) in thermochemical ablation. Conference. Imaging mass spectrometry of image‐guided drug delivery (IGDD) in thermochemical ablation. Indianapolis, IN, US.
- 2017. Distinguishing non‐small cell lung cancer subtypes by desorption electrospray ionization mass spectrometry. Conference. Distinguishing non‐small cell lung cancer subtypes by desorption electrospray ionization mass spectrometry. Indianapolis, IN, US.
- 2017. High intensity focused ultrasound (HIFU): What junior radiologists need to know!. Conference. High intensity focused ultrasound (HIFU): What junior radiologists need to know!. Washington, DC, US.
- 2017. Real‐time monitoring of tumor‐specific indocyanine green hepatic photothermal ablation using photoacoustic imaging. Conference. Real‐time monitoring of tumor‐specific indocyanine green hepatic photothermal ablation using photoacoustic imaging. Washington, DC, US.
- 2016. Hyperchemical ablation: Exothermic neutralization of organic amines with dichloroacetic acid. Conference. Hyperchemical ablation: Exothermic neutralization of organic amines with dichloroacetic acid. New Orleans, LA, US.
- 2016. Complete neutralization of available nitrogen atoms in polyamines using dichloroacetic acid improves mass efficiency in thermochemical ablation. Conference. Complete neutralization of available nitrogen atoms in polyamines using dichloroacetic acid improves mass efficiency in thermochemical ablation. New Orleans, LA, US.
- 2016. Transarterial delivery of a dichloroacetyl chloride/lipiodol mixture in porcine kidney: A proof of concept study for thermochemical embolization. Conference. Transarterial delivery of a dichloroacetyl chloride/lipiodol mixture in porcine kidney: A proof of concept study for thermochemical embolization. New Orleans, LA, US.
- 2016. Extreme exotherms using polyprotic acids with polyamines for thermochemical ablation. Conference. Extreme exotherms using polyprotic acids with polyamines for thermochemical ablation. New Orleans, LA, US.
- 2015. Grants and education update: Proposal for a new direction. Conference. Grants and education update: Proposal for a new direction. Washington DC, MD, US.
- 2015. Evaluation of exotherms of the polyamine analog, diethylenetriamine, with partial to complete neutralization by acetic acid. Conference. Evaluation of exotherms of the polyamine analog, diethylenetriamine, with partial to complete neutralization by acetic acid. Orlando, FL, US.
- 2015. Synergistic cytotoxic effects of combined thermal and osmotic stress are consistent across multiple cell lines. Conference. Synergistic cytotoxic effects of combined thermal and osmotic stress are consistent across multiple cell lines, FL, US.
- 2015. Increasing energy density with polyprotic acids and polyamines for use in thermochemical ablation. Conference. Increasing energy density with polyprotic acids and polyamines for use in thermochemical ablation, FL, US.
- 2014. Hyperpolarized 29Si magnetic resonance - Towards applications in MR guided catheter tracking and targeted imaging of cancer. Conference. Hyperpolarized 29Si magnetic resonance - Towards applications in MR guided catheter tracking and targeted imaging of cancer, TX, US.
- 2014. Master's speak: Early disease, good performance status and focal lesion - Ablation and TACE. Conference. Master's speak: Early disease, good performance status and focal lesion - Ablation and TACE. San Francisco, CA, US.
- 2014. Ethiodol and ethanol TACE: Technique and results. Conference. Ethiodol and ethanol TACE: Technique and results. San Francisco, CA, US.
- 2014. Hands-on workshop III: Ablation. Conference. Hands-on workshop III: Ablation. San Francisco, CA, US.
- 2014. A Dual mode ultrasound array imaging interpretation for high intensity focused ultrasound therapy in ex vivo models. Conference. A Dual mode ultrasound array imaging interpretation for high intensity focused ultrasound therapy in ex vivo models, CA, US.
- 2014. Exothermic neutralization of valproic acid: Combination thermochemical ablation with drug therapy. Conference. Exothermic neutralization of valproic acid: Combination thermochemical ablation with drug therapy, CA, US.
- 2014. Simulations study on cost-effectiveness of radioembolization compared with trans-arterial chemoembolization for hepatocellular carcinoma. Conference. Simulations study on cost-effectiveness of radioembolization compared with trans-arterial chemoembolization for hepatocellular carcinoma, CA, US.
- 2013. Feasibility of high intensity focused ultrasound (HIFU) for treatment of polycystic ovarian syndrome: Potential for non-invasive treatment. Conference. Feasibility of high intensity focused ultrasound (HIFU) for treatment of polycystic ovarian syndrome: Potential for non-invasive treatment, LA, US.
- 2013. Transarterial lipiodiol–ethanol ablation of the hepatocellular carcinoma; A single center initial U.S. experience. Conference. Transarterial lipiodiol–ethanol ablation of the hepatocellular carcinoma; A single center initial U.S. experience, LA, US.
- 2012. Feasibility of targeting atheromatous plaques by high intensity focused ultrasound using dual-mode transducers: An early experience. Conference. Feasibility of targeting atheromatous plaques by high intensity focused ultrasound using dual-mode transducers: An early experience, CA, US.
- 2011. Thermochemical ablation in-vivo: Comparison of two injection methods in a porcine model. Conference. Thermochemical ablation in-vivo: Comparison of two injection methods in a porcine model. New Orleans, LA, US.
- 2011. Real time two-dimensional temperature imaging for monitoring and control of multiple-focus HIFU beams. Conference. Real time two-dimensional temperature imaging for monitoring and control of multiple-focus HIFU beams. New Orleans, LA, US.
- 2011. In-vivo thermochemical ablation using sodium hydroxide and acetic acid in a porcine model: Temperature, coagulation volume, and sphericity analyses. Conference. In-vivo thermochemical ablation using sodium hydroxide and acetic acid in a porcine model: Temperature, coagulation volume, and sphericity analyses. New Orleans, LA, US.
- 2011. Scanning Fourier transform infra-red (FTIR) evaluation of the impact of protein denaturation on survival after thermochemical ablation of HUH-7 liver cancer. Conference. Scanning Fourier transform infra-red (FTIR) evaluation of the impact of protein denaturation on survival after thermochemical ablation of HUH-7 liver cancer. New Orleans, LA, US.
- 2010. Cost of renal dysfunction after TACE: Dollars and lives. Conference. Cost of renal dysfunction after TACE: Dollars and lives. San Francisco, CA, US.
- 2010. Trifluoroacetic acid: A thermochemical ablation agent with 19F MRI potential. Conference. Trifluoroacetic acid: A thermochemical ablation agent with 19F MRI potential. Clearwater, FL, US.
- 2010. Autofluorescence distinguishes ablated from normal liver: Evaluation of a high-background tissue. Conference. Autofluorescence distinguishes ablated from normal liver: Evaluation of a high-background tissue. Clearwater, FL, US.
- 2010. Real-time multi-point temperature control based on noninvasive ultrasound thermography. Conference. Real-time multi-point temperature control based on noninvasive ultrasound thermography. Clearwater, FL, US.
- 2010. Citric acid: A natural thermochemical ablation agent. Conference. Citric acid: A natural thermochemical ablation agent. Clearwater, FL, US.
- 2010. A simple microscale device for application to thermochemical ablation research in rodent models. Conference. A simple microscale device for application to thermochemical ablation research in rodent models. Clearwater, FL, US.
- 2010. Polyprotic mineral acids as powerful reagents in thermochemical ablation. Conference. Polyprotic mineral acids as powerful reagents in thermochemical ablation. Clearwater, FL, US.
- 2010. Redox chemistry: A powerful energy source for thermochemical ablation. Conference. Redox chemistry: A powerful energy source for thermochemical ablation. Clearwater, FL, US.
- 2009. In-vitro and ex-vivo analysis of HCl, HBr and HI as radiodense thermochemical ablation agents. Conference. In-vitro and ex-vivo analysis of HCl, HBr and HI as radiodense thermochemical ablation agents. Tucson, AZ, US.
- 2009. Malonyl chloride as an energetic, bifunctional thermochemical ablation agent. Conference. Malonyl chloride as an energetic, bifunctional thermochemical ablation agent. Tucson, AZ, US.
- 2009. Hyperthermic ethanol generated in situ: Initial assessment of the electrophile ethyl chloroformate for thermochemical ablation. Conference. Hyperthermic ethanol generated in situ: Initial assessment of the electrophile ethyl chloroformate for thermochemical ablation. Tucson, AZ, US.
- 2008. Use of non-invasive balloon catheters placed under fluoroscopic guidance for delivery of the Sleeping Beauty transposon system under pressure to the liver of dogs. Conference. Use of non-invasive balloon catheters placed under fluoroscopic guidance for delivery of the Sleeping Beauty transposon system under pressure to the liver of dogs. Boston, MA, US.
- 2007. Cytotoxicity of heterocyclic enediynes in HuH7 and HeLa cells. Conference. Cytotoxicity of heterocyclic enediynes in HuH7 and HeLa cells, MN, US.
- 2006. Hyphenating solid tissue sampling with capillary electrophoresis. Conference. Hyphenating solid tissue sampling with capillary electrophoresis. Orlando, FL, US.
- 2002. Preliminary results of in vivo effects of benzamide riboside on rabbit VX2 liver tumors. Conference. Preliminary results of in vivo effects of benzamide riboside on rabbit VX2 liver tumors, US.
- 1993. Studies directed toward the synthesis of the rhizoxins. Conference. Studies directed toward the synthesis of the rhizoxins, CO, US.
- 1987. Studies in pyrrolizidine alkaloid synthesis. Conference. Studies in pyrrolizidine alkaloid synthesis, CO, US.
International Presentations
- 2024. Thermochemical ablation. Conference. Lisbon, PT.
- 2023. Early experience with tumors generated in the Oncopig characterized by Mass Spectrometry Imaging and Computed Tomography. Conference. Early experience with tumors generated in the Oncopig characterized by Mass Spectrometry Imaging and Computed Tomography. Montreal, CA.
- 2020. Cesium ion doping enables mass spectrometry imaging of product distribution of thermochemical ablation. Conference. Cesium ion doping enables mass spectrometry imaging of product distribution of thermochemical ablation. Basel, CH.
- 2019. Evaluation of trifluoroacetic acid as a theranostic fluorine-19 MRI agent for chemical ablation of solid tissue. Conference. Evaluation of trifluoroacetic acid as a theranostic fluorine-19 MRI agent for chemical ablation of solid tissue. Montreal, CA.
- 2019. Thermochemical ablation: A novel application of fluorine-19 magnetic resonance imaging. Conference. Thermochemical ablation: A novel application of fluorine-19 magnetic resonance imaging. Montreal, CA.
- 2018. Photoacoustic imaging for spectral characterization and thermography of ex vivo thermochemical ablation. Conference. Photoacoustic imaging for spectral characterization and thermography of ex vivo thermochemical ablation. Lisbon, PT.
- 2017. MRI-based real-time characterization of thermoembolization. Conference. MRI-based real-time characterization of thermoembolization, MX.
- 2017. Theranostic multiplexed thermochemical ablation (MTCA): Tracking dichloroacetate using multi-energy computed tomography. Conference. Theranostic multiplexed thermochemical ablation (MTCA): Tracking dichloroacetate using multi-energy computed tomography, MX.
- 2017. Multi-energy computed tomography (MECT) imaging of endovascular ablation: thermoembolization in an ex-vivo porcine kidney model. Conference. Multi-energy computed tomography (MECT) imaging of endovascular ablation: thermoembolization in an ex-vivo porcine kidney model, MX.
- 2016. Time-resolved 23Na imaging for monitoring of thermochemical ablation injections. Conference. Time-resolved 23Na imaging for monitoring of thermochemical ablation injections, SG.
- 2016. Dose escalation and mechanistic studies in combined thermal and osmotic stress in hepatocellular carcinoma cell lines. Conference. Dose escalation and mechanistic studies in combined thermal and osmotic stress in hepatocellular carcinoma cell lines. Vancouver, CA.
- 2016. Metabolic modulation with dichloroacetate sensitizes cells to hyperthermia in human hepatocellular carcinoma cell lines. Conference. Metabolic modulation with dichloroacetate sensitizes cells to hyperthermia in human hepatocellular carcinoma cell lines. Vancouver, British Columbia, CA.
- 2011. In-vivo simultaneous versus sequential thermochemical ablation: Imaging, histopathology, and physiologic responses. Conference. In-vivo simultaneous versus sequential thermochemical ablation: Imaging, histopathology, and physiologic responses. New York, US.
- 2011. Transarterial chemoembolization in patients with elevated serum bilirubin. Conference. Transarterial chemoembolization in patients with elevated serum bilirubin. Vienna, AU.
- 2010. Dual mode ultrasound array (DUMA) systems for image-guided surgery. Conference. Dual mode ultrasound array (DUMA) systems for image-guided surgery. Philadelphia, US.
- 2010. Malonyl chloride as a powerful thermochemical ablation agent: Ex-vivo volume studies and histological analysis. Conference. Malonyl chloride as a powerful thermochemical ablation agent: Ex-vivo volume studies and histological analysis. Philadelphia, US.
- 2010. Does pre-chemoembolization MELD score correlate with survival time?. Conference. Does pre-chemoembolization MELD score correlate with survival time?. Vienna, AT.
- 2009. The road less traveled: Combining an MD and PhD to establish a research program in biomedicine. Conference. The road less traveled: Combining an MD and PhD to establish a research program in biomedicine. Minneapolis, US.
- 2009. Image-guided thermochemical ablation: Theoretical and practical considerations. Conference. Image-guided thermochemical ablation: Theoretical and practical considerations. Minneapolis, US.
Formal Peers
- 2023. Interventional Biology: The New Frontier?. Invited. Interventional Biology: The New Frontier?. Montreal, Quebec, CA.
- 2021. Biomedical Engineering Graduate Seminar: It’s at the Crossroads of Interventional Radiology and Chemistry. Invited. Biomedical Engineering Graduate Seminar: It’s at the Crossroads of Interventional Radiology and Chemistry. College Station, TX, US.
- 2021. Introduction to Interventional Radiology. Invited. Introduction to Interventional Radiology. Houston, TX, US.
- 2021. Evolution and Alteration of the Tumor Microenvironment. Invited. Evolution and Alteration of the Tumor Microenvironment. Austin, TX, US.
- 2021. ASLMS / STM Cell Stress Pathways and Energy-Based Devices. Invited. ASLMS / STM Cell Stress Pathways and Energy-Based Devices, US.
- 2018. Introduction to Mass Spectrometry Imaging. Visiting. Introduction to Mass Spectrometry Imaging. Houston, TX, US.
- 2018. Introduction to IR. Visiting. Introduction to IR. Houston, TX, US.
- 2016. Challenges and new frontiers in solid tumor ablation. Invited. Challenges and new frontiers in solid tumor ablation. Heidelberg, DE.
- 2014. Small is Beautiful. Visiting. Small is Beautiful, HI, US.
- 2014. Interventional Radiology Introduction for Graduate Students. Visiting. Interventional Radiology Introduction for Graduate Students. Houston, TX, US.
- 2014. The Science Behind Ablative Therapies. Visiting. The Science Behind Ablative Therapies. San Francisco, CA, US.
- 2014. Combination Therapy: RF and TACE. Visiting. Combination Therapy: RF and TACE, CA, US.
- 2014. Cytotoxic Interactions of Heat and Salt Exposure Using Sodium Acetate in Murine 4T1 Breast Carcinoma Cells. Visiting. Cytotoxic Interactions of Heat and Salt Exposure Using Sodium Acetate in Murine 4T1 Breast Carcinoma Cells, MN, US.
- 2013. Emerging Technologies in Ablation. Visiting. Emerging Technologies in Ablation. Minneapolis, MN, US.
- 2012. Thermochemistry: A Multifaceted Alternative Energy Source for Ablation. Visiting. Thermochemistry: A Multifaceted Alternative Energy Source for Ablation. Kyoto, JP.
- 2012. Patient Selection: Which Lab Tests Draw What lines. Visiting. Patient Selection: Which Lab Tests Draw What lines. New York, NY, US.
- 2012. Recent Developments in DMUA HIFU. Visiting. Recent Developments in DMUA HIFU. Houston, TX, US.
- 2012. Thermochemical Ablation. Visiting. Thermochemical Ablation. Houston, TX, US.
- 2011. Fire in the Hole: Adventures in Thermochemical Ablation. Visiting. Fire in the Hole: Adventures in Thermochemical Ablation. Denver, CO, US.
- 2011. Getting Started in IR Research. Visiting. Getting Started in IR Research. Chicago, IL, US.
- 2010. Known Thine Enemy: The Molecular Biology of HCC. Visiting. Known Thine Enemy: The Molecular Biology of HCC. Philadelphia, PA, US.
- 2010. Thermochemical Ablation. Visiting. Thermochemical Ablation. Minneapolis, MN, US.
- 2010. Getting Started in IR Research. Visiting. Getting Started in IR Research. Tampa, FL, US.
- 2009. Tumor Imaging. Visiting. Tumor Imaging. Minneapolis, MN, US.
- 2009. Image-guided Thermochemical Ablation. Visiting. Image-guided Thermochemical Ablation. Minneapolis, MN, US.
- 2009. The Road Less Traveled: Combining an MD and PhD to Establish a Research Program in Biomedicine. Visiting. The Road Less Traveled: Combining an MD and PhD to Establish a Research Program in Biomedicine. Minneapolis, MN, US.
- 2009. Interventional Oncology 101. Visiting. Interventional Oncology 101. Little Rock, AR, US.
- 2009. Exothermic Chemistry: All Hot and Bothered?. Visiting. Exothermic Chemistry: All Hot and Bothered?. Little Rock, AR, US.
- 2008. Prometheus: Interventional Oncologist of Mythical Proportions?. Visiting. Prometheus: Interventional Oncologist of Mythical Proportions?. Bethesda, MD, US.
- 2008. Tumor Ablation 101. Visiting. Tumor Ablation 101. Minneapolis, MN, US.
- 2007. Starting a Research Career. Visiting. Starting a Research Career. Seattle, WA, US.
Grant & Contract Support
Date: | 2025 - 2029 |
Title: | Advancing Cancer Treatment with Thermoembolization: A Multi-Disciplinary ForceMultiplier Approach |
Funding Source: | NIH |
Role: | PI |
ID: | 1R01CA301555-01 |
Date: | 2023 - 2028 |
Title: | Reactive Embolization for Selective and Effective Treatment of Solid Tumors |
Funding Source: | NIH/NCI |
Role: | PI |
Date: | 2023 - 2028 |
Title: | In Vivo Chemistry As A New Approach To Treat Solid Tumors |
Funding Source: | NIH/NCI |
Role: | PI |
ID: | 1 R01 CA281013-01 |
Date: | 2023 - 2028 |
Title: | An image-guided immunotherapy and hyperthermia delivery device to overcome barriers to tumor immunity for advanced hepatocellular carcinoma |
Funding Source: | NIH/NCI |
Role: | Co-I |
ID: | 1R37CA269622-01A1 |
Date: | 2022 - 2027 |
Title: | Image Guided Cancer Therapy Training Program |
Funding Source: | NIH/NCI |
Role: | Preceptor |
ID: | 1T32CA261856-01A1 |
Date: | 2022 - 2027 |
Title: | Interdisciplinary translational pre/postdoctoral program in cancer nanotechnology |
Funding Source: | NIH/NCI |
Role: | Mentor |
ID: | 2T32CA196561-06 |
Date: | 2022 - 2024 |
Title: | Characterization of endovascular ablative therapies with computational modeling |
Funding Source: | NIH/NCI |
Role: | Collaborator |
ID: | 1R21CA260016-01A1 |
Date: | 2021 - 2023 |
Title: | Characterization of thermoembolization cellular damage with computational modeling |
Funding Source: | The Oden Institute for Computational Engineering and Sciences, The University of Texas MD Anderson Cancer Center, and Texas Advanced Computing Center (TACC) |
Role: | Co-PI |
Date: | 2021 - 2025 |
Title: | Biopsy tract sealing device with magnetic resonance and x-ray image contrast |
Funding Source: | NIH/NCI |
Role: | Co-I |
ID: | 1R01CA254964-01 |
Date: | 2020 - 2021 |
Title: | Development of an inducible large animal model of cancer |
Funding Source: | MD Anderson Cancer Center Internal Funding |
Role: | PI |
Date: | 2020 - 2021 |
Title: | Portal Venous Catheter Study in a Pig Model |
Funding Source: | Thunar Medical |
Role: | PI |
Date: | 2019 - 2020 |
Title: | Multimodal reactive embolization: Mechanism, imaging, and systemic effects |
Funding Source: | Bridge Funding Support |
Role: | PI |
Date: | 2019 - 2021 |
Title: | Molecularly targeted photothermal ablation to enhance the therapeutic efficacy of immunomodulatory therapies in hepatocellular carcinoma |
Funding Source: | NIH/NIBIB |
Role: | Co-I |
ID: | 1 R21 EB026089-01A1 |
Date: | 2018 - 2019 |
Title: | Ernest J. Ring Junior Faculty Development Award |
Funding Source: | SIR Foundation |
Role: | Mentor |
Date: | 2017 - 2018 |
Title: | Multiplexed ablation through metabolic modulation |
Funding Source: | Bridge Funding Support |
Role: | PI |
Date: | 2016 - 2017 |
Title: | Thermoembolization: A fundamentally new tactical weapon for primary and metastatic disease |
Funding Source: | IRG |
Role: | Principal Investigator-MDACC |
Date: | 2016 - 2019 |
Title: | Antitumor immune activation by molecularly targeted photothermal ablation for the treatment of hepatocellular carcinoma |
Funding Source: | Radiological Society of North America |
Role: | Mentor |
Date: | 2016 - 2023 |
Title: | Simultaneous thermal and osmotic stress in tumor ablation: Imaging and biology |
Funding Source: | NIH/NCI |
Role: | PI |
ID: | 1R01CA201127-01A1 |
Date: | 2016 - 2018 |
Title: | Rapid molecular diagnosis of lung cancer by ambient ionization mass spectrometry |
Funding Source: | Cancer Prevention & Research Institute of Texas (CPRIT) |
Role: | Co-I |
Date: | 2016 - 2017 |
Title: | Simultaneous thermal osmotic stresses in tumor ablation: Imaging and biology |
Funding Source: | Bridge Funding Support |
Role: | PI |
Date: | 2015 - 2016 |
Title: | Evaluation of spiral-based 3D MR thermometry for brain applications of MR-guided focused ultrasound in a porcine model |
Funding Source: | RSNA |
Role: | Mentor |
Date: | 2014 - 2014 |
Title: | Directed evolution of imaging agents by mRNA display in large animals |
Funding Source: | NIH/NCI |
Role: | Co-PI |
Date: | 2012 - 2014 |
Title: | Dual-mode ultrasound array system for noninvasive, image-guided targeted drug delivery in vivo Minnesota futures grant |
Funding Source: | NIH/NCI |
Role: | Co-PI |
Date: | 2008 - 2010 |
Title: | Thermochemical ablation in image-guided interventions: initial assessment |
Funding Source: | NIH/NCI |
Role: | PI |
Date: | 2007 - 2008 |
Title: | Thermochemical ablation: a new frontier in Interventional Oncology |
Funding Source: | Society of Interventional Radiology Foundation |
Role: | PI |
Date: | 2006 - 2007 |
Title: | Fluorescence microscopy evaluation of permeability enhancement in drug delivery |
Funding Source: | Minnesota Medical Foundation Project Grant |
Role: | PI |
Date: | 2006 - 2007 |
Title: | Changes in pH with acetic acid tissue ablation in rabbit liver and neutralization with base |
Funding Source: | University of Minnesota Graduate School Grant-in Aid |
Role: | PI |
Date: | 2003 - 2004 |
Title: | In vivo activity of benzamide riboside in liver cancers |
Funding Source: | CIRREF Pilot Grant |
Role: | Co-I |
Title: | Delivery optimization of a transarterial ablative therapy |
Funding Source: | NIH/NCI |
Role: | PI |
ID: | 1R01CA301555-01 |
Title: | Cancer Prevention and Research Institute of Texas (CPRIT), revealing fundamental aspects of pH in tumor biology, cell stress, and therapeutic vulnerability through a synergistic, multiplexed, minimally-invasive approach |
Funding Source: | Cancer Prevention & Research Institute of Texas (CPRIT) |
Role: | Project Leader |
Title: | Targeted Reversal of Acidic pH in the Tumor Microenvironment |
Funding Source: | NIH/NCI |
Role: | Co-PI |
Title: | Establishing the Foundations for Image-Guided Chemoproteomics |
Funding Source: | Welch Foundation |
Role: | Co-PI |
Patient Reviews
CV information above last modified March 31, 2025